-
Je něco špatně v tomto záznamu ?
High-Affinity N-(2-Hydroxypropyl)methacrylamide Copolymers with Tailored N-Acetyllactosamine Presentation Discriminate between Galectins
MR. Tavares, M. Bláhová, L. Sedláková, L. Elling, H. Pelantová, R. Konefał, T. Etrych, V. Křen, P. Bojarová, P. Chytil
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- akrylamidy chemie MeSH
- aminocukry chemie MeSH
- Bacillus enzymologie MeSH
- beta-galaktosidasa metabolismus MeSH
- disacharidy chemická syntéza MeSH
- ELISA MeSH
- epitopy MeSH
- galektin 1 analýza metabolismus MeSH
- galektiny analýza metabolismus MeSH
- katalýza MeSH
- krevní proteiny analýza metabolismus MeSH
- magnetická rezonanční spektroskopie MeSH
- polymerizace MeSH
- polymery chemie metabolismus farmakologie MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
N-Acetyllactosamine (LacNAc; Galβ4GlcNAc) is a typical disaccharide ligand of galectins. The most abundant members of these human lectins, galectin-1 (Gal-1) and galectin-3 (Gal-3), participate in a number of pathologies including cancerogenesis and metastatic formation. In this study, we synthesized a series of fifteen N-(2-hydroxypropyl)methacrylamide (HPMA)-based glycopolymers with varying LacNAc amounts and presentations and evaluated the impact of their architecture on the binding affinity to Gal-1 and Gal-3. The controlled radical reversible addition-fragmentation chain transfer copolymerization technique afforded linear polymer precursors with comparable molecular weight (Mn ≈ 22,000 g mol-1) and narrow dispersity (D̵ ≈ 1.1). The precursors were conjugated with the functionalized LacNAc disaccharide (4-22 mol % content in glycopolymer) prepared by enzymatic synthesis under catalysis by β-galactosidase from Bacillus circulans. The structure-affinity relationship study based on the enzyme-linked immunosorbent assay revealed that the type of LacNAc presentation, individual or clustered on bi- or trivalent linkers, brings a clear discrimination (almost 300-fold) between Gal-1 and Gal-3, reaching avidity to Gal-1 in the nanomolar range. Whereas Gal-1 strongly preferred a dense presentation of individually distributed LacNAc epitopes, Gal-3 preferred a clustered LacNAc presentation. Such a strong galectin preference based just on the structure of a multivalent glycopolymer type is exceptional. The prepared nontoxic, nonimmunogenic, and biocompatible glycopolymers are prospective for therapeutic applications requiring selectivity for one particular galectin.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21020750
- 003
- CZ-PrNML
- 005
- 20210830102409.0
- 007
- ta
- 008
- 210728s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.biomac.9b01370 $2 doi
- 035 __
- $a (PubMed)31904940
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Tavares, Marina Rodrigues $u Institute of Macromolecular Chemistry , Czech Academy of Sciences , Heyrovského náměstí 2 , CZ-162 06 Prague 6 , Czech Republic
- 245 10
- $a High-Affinity N-(2-Hydroxypropyl)methacrylamide Copolymers with Tailored N-Acetyllactosamine Presentation Discriminate between Galectins / $c MR. Tavares, M. Bláhová, L. Sedláková, L. Elling, H. Pelantová, R. Konefał, T. Etrych, V. Křen, P. Bojarová, P. Chytil
- 520 9_
- $a N-Acetyllactosamine (LacNAc; Galβ4GlcNAc) is a typical disaccharide ligand of galectins. The most abundant members of these human lectins, galectin-1 (Gal-1) and galectin-3 (Gal-3), participate in a number of pathologies including cancerogenesis and metastatic formation. In this study, we synthesized a series of fifteen N-(2-hydroxypropyl)methacrylamide (HPMA)-based glycopolymers with varying LacNAc amounts and presentations and evaluated the impact of their architecture on the binding affinity to Gal-1 and Gal-3. The controlled radical reversible addition-fragmentation chain transfer copolymerization technique afforded linear polymer precursors with comparable molecular weight (Mn ≈ 22,000 g mol-1) and narrow dispersity (D̵ ≈ 1.1). The precursors were conjugated with the functionalized LacNAc disaccharide (4-22 mol % content in glycopolymer) prepared by enzymatic synthesis under catalysis by β-galactosidase from Bacillus circulans. The structure-affinity relationship study based on the enzyme-linked immunosorbent assay revealed that the type of LacNAc presentation, individual or clustered on bi- or trivalent linkers, brings a clear discrimination (almost 300-fold) between Gal-1 and Gal-3, reaching avidity to Gal-1 in the nanomolar range. Whereas Gal-1 strongly preferred a dense presentation of individually distributed LacNAc epitopes, Gal-3 preferred a clustered LacNAc presentation. Such a strong galectin preference based just on the structure of a multivalent glycopolymer type is exceptional. The prepared nontoxic, nonimmunogenic, and biocompatible glycopolymers are prospective for therapeutic applications requiring selectivity for one particular galectin.
- 650 _2
- $a akrylamidy $x chemie $7 D000178
- 650 _2
- $a aminocukry $x chemie $7 D000606
- 650 _2
- $a Bacillus $x enzymologie $7 D001407
- 650 _2
- $a krevní proteiny $x analýza $x metabolismus $7 D001798
- 650 _2
- $a katalýza $7 D002384
- 650 _2
- $a disacharidy $x chemická syntéza $7 D004187
- 650 _2
- $a ELISA $7 D004797
- 650 _2
- $a epitopy $7 D000939
- 650 _2
- $a galektin 1 $x analýza $x metabolismus $7 D037483
- 650 _2
- $a galektiny $x analýza $x metabolismus $7 D037161
- 650 _2
- $a magnetická rezonanční spektroskopie $7 D009682
- 650 _2
- $a polymerizace $7 D058105
- 650 _2
- $a polymery $x chemie $x metabolismus $x farmakologie $7 D011108
- 650 _2
- $a beta-galaktosidasa $x metabolismus $7 D001616
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bláhová, Markéta $u Institute of Macromolecular Chemistry , Czech Academy of Sciences , Heyrovského náměstí 2 , CZ-162 06 Prague 6 , Czech Republic
- 700 1_
- $a Sedláková, Lieselotte $u Institute of Microbiology , Czech Academy of Sciences , Vídeňská 1083 , CZ-142 20 Prague 4 , Czech Republic $u Department of Health Care Disciplines and Population Protection, Faculty of Biomedical Engineering , Czech Technical University in Prague , Sítná sq. 3105 , CZ-272 01 Kladno , Czech Republic
- 700 1_
- $a Elling, Lothar $u Institute of Biotechnology and Helmholtz Institute for Biomedical Engineering , RWTH Aachen , Pauwelstr. 20 , D-52079 Aachen , Germany
- 700 1_
- $a Pelantová, Helena $u Institute of Microbiology , Czech Academy of Sciences , Vídeňská 1083 , CZ-142 20 Prague 4 , Czech Republic
- 700 1_
- $a Konefał, Rafał $u Institute of Macromolecular Chemistry , Czech Academy of Sciences , Heyrovského náměstí 2 , CZ-162 06 Prague 6 , Czech Republic
- 700 1_
- $a Etrych, Tomáš $u Institute of Macromolecular Chemistry , Czech Academy of Sciences , Heyrovského náměstí 2 , CZ-162 06 Prague 6 , Czech Republic
- 700 1_
- $a Křen, Vladimír $u Institute of Microbiology , Czech Academy of Sciences , Vídeňská 1083 , CZ-142 20 Prague 4 , Czech Republic
- 700 1_
- $a Bojarová, Pavla $u Institute of Microbiology , Czech Academy of Sciences , Vídeňská 1083 , CZ-142 20 Prague 4 , Czech Republic $u Department of Health Care Disciplines and Population Protection, Faculty of Biomedical Engineering , Czech Technical University in Prague , Sítná sq. 3105 , CZ-272 01 Kladno , Czech Republic
- 700 1_
- $a Chytil, Petr $u Institute of Macromolecular Chemistry , Czech Academy of Sciences , Heyrovského náměstí 2 , CZ-162 06 Prague 6 , Czech Republic
- 773 0_
- $w MED00006456 $t Biomacromolecules $x 1526-4602 $g Roč. 21, č. 2 (2020), s. 641-652
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31904940 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830102409 $b ABA008
- 999 __
- $a ok $b bmc $g 1691344 $s 1141196
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 21 $c 2 $d 641-652 $e 20200123 $i 1526-4602 $m Biomacromolecules $n Biomacromolecules $x MED00006456
- LZP __
- $a Pubmed-20210728